<code id='6A49C0E33B'></code><style id='6A49C0E33B'></style>
    • <acronym id='6A49C0E33B'></acronym>
      <center id='6A49C0E33B'><center id='6A49C0E33B'><tfoot id='6A49C0E33B'></tfoot></center><abbr id='6A49C0E33B'><dir id='6A49C0E33B'><tfoot id='6A49C0E33B'></tfoot><noframes id='6A49C0E33B'>

    • <optgroup id='6A49C0E33B'><strike id='6A49C0E33B'><sup id='6A49C0E33B'></sup></strike><code id='6A49C0E33B'></code></optgroup>
        1. <b id='6A49C0E33B'><label id='6A49C0E33B'><select id='6A49C0E33B'><dt id='6A49C0E33B'><span id='6A49C0E33B'></span></dt></select></label></b><u id='6A49C0E33B'></u>
          <i id='6A49C0E33B'><strike id='6A49C0E33B'><tt id='6A49C0E33B'><pre id='6A49C0E33B'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:434
          Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

          Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

          Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

          advertisement

          Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          I learned firsthand about improving diversity in clinical trials
          I learned firsthand about improving diversity in clinical trials

          Asthebiopharmaceuticalindustryplacesincreasedemphasisonimprovingthediversityofparticipantsinclinical

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Awakening the world to the whoosh: A patient's crusade

          ErosDervishiforSTATSevenyearsago,NewYorklawyerEmmaGreenwoodawoketothebeatofapulseononesideofherhead.